AtriCure (ATRC) Misses Q1 EPS by 3c ; Offers Guidance

AtriCure (NASDAQ: ATRC) reported Q1 EPS of ($0.25), $0.03 worse than the analyst estimate of ($0.22). Revenue for the quarter came in at $108.9 million versus the consensus estimate of $106.91 million.

GUIDANCE:

AtriCure sees FY2024 EPS of ($0.74)-($0.82), versus the consensus of ($0.76). AtriCure sees FY2024 revenue of $459-466 million, versus the consensus of $461.2 million.

For earnings history and earnings-related data on AtriCure (ATRC) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• St. James's Place plc (STJ:LN) (STJPF) PT Raised to GBP20.50 at Deutsche Bank
• BofA lists top 5 themes driving next $1tn in incremental semi sales